Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9058 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.9058 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8993 |
High Similarity |
NPD1549 |
Phase 2 |
0.8759 |
High Similarity |
NPD1240 |
Approved |
0.875 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8714 |
High Similarity |
NPD2796 |
Approved |
0.8643 |
High Similarity |
NPD1510 |
Phase 2 |
0.8633 |
High Similarity |
NPD1607 |
Approved |
0.8621 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.86 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8533 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8462 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8425 |
Intermediate Similarity |
NPD6799 |
Approved |
0.84 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8369 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8366 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8289 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8276 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8214 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8212 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD1511 |
Approved |
0.817 |
Intermediate Similarity |
NPD2801 |
Approved |
0.817 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8121 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8121 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8089 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8069 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8067 |
Intermediate Similarity |
NPD1512 |
Approved |
0.805 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.805 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.805 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8027 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7973 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7973 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7945 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7945 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7937 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7905 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7905 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7901 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7899 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7898 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7895 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7885 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7853 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.784 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7799 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7791 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7778 |
Intermediate Similarity |
NPD920 |
Approved |
0.777 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7763 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7755 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7755 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7748 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7733 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7733 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7711 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7698 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7697 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7683 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7671 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7671 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7664 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7635 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7605 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7586 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7571 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7566 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7561 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7551 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7547 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7545 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7518 |
Intermediate Similarity |
NPD9493 |
Approved |
0.75 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7483 |
Intermediate Similarity |
NPD943 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7431 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7431 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7426 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7425 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD919 |
Approved |
0.74 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7394 |
Intermediate Similarity |
NPD2403 |
Approved |
0.7381 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7378 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7371 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7347 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7347 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7347 |
Intermediate Similarity |
NPD411 |
Approved |
0.7347 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7337 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7317 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7315 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7308 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7244 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7241 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7232 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7172 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7171 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7133 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7133 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7113 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7107 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7089 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4662 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7078 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7063 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7063 |
Intermediate Similarity |
NPD17 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7047 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7035 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7019 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7019 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7012 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7006 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD3764 |
Approved |
0.6994 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6992 |
Remote Similarity |
NPD940 |
Approved |
0.6992 |
Remote Similarity |
NPD846 |
Approved |
0.6982 |
Remote Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6966 |
Remote Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD4287 |
Approved |
0.6939 |
Remote Similarity |
NPD1876 |
Approved |
0.6935 |
Remote Similarity |
NPD7584 |
Approved |
0.6934 |
Remote Similarity |
NPD74 |
Approved |
0.6934 |
Remote Similarity |
NPD9266 |
Approved |
0.6934 |
Remote Similarity |
NPD2684 |
Approved |
0.6932 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD1894 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD7213 |
Phase 3 |
0.6918 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6918 |
Remote Similarity |
NPD7212 |
Phase 2 |
0.6909
|
Remote Similarity |
NPD5353 |
Approved |